These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9207619)

  • 1. Patients with mild heart failure worsen during withdrawal from digoxin therapy.
    Adams KF; Gheorghiade M; Uretsky BF; Young JB; Ahmed S; Tomasko L; Packer M
    J Am Coll Cardiol; 1997 Jul; 30(1):42-8. PubMed ID: 9207619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
    Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
    J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy.
    Adams KF; Gheorghiade M; Uretsky BF; Young JB; Patterson JH; Tomasko L; Packer M
    Am Heart J; 1998 Mar; 135(3):389-97. PubMed ID: 9506323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
    J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefits of low serum digoxin concentrations in heart failure.
    Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin use in congestive heart failure. Current status.
    Riaz K; Forker AD
    Drugs; 1998 Jun; 55(6):747-58. PubMed ID: 9617590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure.
    Ward RE; Gheorghiade M; Young JB; Uretsky B
    J Am Coll Cardiol; 1995 Jul; 26(1):93-101. PubMed ID: 7797781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.
    Udelson JE; DeAbate CA; Berk M; Neuberg G; Packer M; Vijay NK; Gorwitt J; Smith WB; Kukin ML; LeJemtel T; Levine TB; Konstam MA
    Am Heart J; 2000 Mar; 139(3):503-10. PubMed ID: 10689266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum digoxin concentration and outcomes in patients with heart failure.
    Rathore SS; Curtis JP; Wang Y; Bristow MR; Krumholz HM
    JAMA; 2003 Feb; 289(7):871-8. PubMed ID: 12588271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin in heart failure: implications of recent trials.
    Kelly RA; Smith TW
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):107A-112A. PubMed ID: 8376681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled, crossover trial.
    Fleg JL; Rothfeld B; Gottlieb SH
    J Am Coll Cardiol; 1991 Mar; 17(3):743-51. PubMed ID: 1993796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.
    Miura T; Kojima R; Mizutani M; Shiga Y; Takatsu F; Suzuki Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):77-83. PubMed ID: 11372597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
    Gheorghiade M; Zarowitz BJ
    Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of digoxin on the quality of life in patients with heart failure.
    Lader E; Egan D; Hunsberger S; Garg R; Czajkowski S; McSherry F
    J Card Fail; 2003 Feb; 9(1):4-12. PubMed ID: 12612867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.